OTCMKTS:WEDXF - Westaim Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.87 -0.08 (-4.10 %) (As of 03/22/2019 04:00 PM ET)Previous Close$1.87Today's Range$1.87 - $1.910152-Week Range$1.73 - $2.5663Volume10,205 shsAverage Volume29,556 shsMarket Capitalization$267.77 millionP/E Ratio16.23Dividend Yield4.94%Beta0.81 ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada. Receive WEDXF News and Ratings via Email Sign-up to receive the latest news and ratings for WEDXF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorBasic Materials Current SymbolOTCMKTS:WEDXF Previous Symbol CUSIPN/A CIK1108828 Webwww.westaim.com Phone416-969-3333Debt Debt-to-Equity Ratio0.11 Current Ratio2.08 Quick Ratio2.08Price-To-Earnings Trailing P/E Ratio16.23 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.70 million Price / Sales72.37 Cash Flow$0.0372 per share Price / Cash Flow50.23 Book Value$2.28 per share Price / Book0.82Profitability EPS (Most Recent Fiscal Year)N/A Net Income$5.57 million Net Margins372.23% Return on Equity5.15% Return on Assets4.38%Miscellaneous Employees8 Outstanding Shares143,190,000Market Cap$267.77 million Next Earnings Date4/4/2019 (Estimated) OptionableNot Optionable Westaim (OTCMKTS:WEDXF) Frequently Asked Questions What is Westaim's stock symbol? Westaim trades on the OTCMKTS under the ticker symbol "WEDXF." When is Westaim's next earnings date? Westaim is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Westaim. Has Westaim been receiving favorable news coverage? News headlines about WEDXF stock have been trending somewhat positive this week, according to InfoTrie. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Westaim earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of Westaim's key competitors? Some companies that are related to Westaim include AtriCure (ATRC), Luminex (LMNX), Orthofix Medical (OFIX), Cryolife (CRY), Intersect ENT (XENT), Cerus (CERS), AngioDynamics (ANGO), OraSure Technologies (OSUR), Orthopediatrics (KIDS), Axonics Modulation Technologies (AXNX), LeMaitre Vascular (LMAT), SurModics (SRDX), Antares Pharma (ATRS), SI-Bone (SIBN) and GenMark Diagnostics (GNMK). What other stocks do shareholders of Westaim own? Based on aggregate information from My MarketBeat watchlists, some companies that other Westaim investors own include Allena Pharmaceuticals (ALNA), Pfizer (PFE), Canadian Imperial Bank of Commerce (CM), AFLAC (AFL), Ampliphi Biosciences (APHB), Cerecor (CERC), AcelRx Pharmaceuticals (ACRX), Pieris Pharmaceuticals (PIRS), New York REIT (NYRT) and MOTIF BIO PLC/S (MTFB). Who are Westaim's key executives? Westaim's management team includes the folowing people: Mr. Ian W. Delaney, Exec. Chairman (Age 75)Mr. John Cameron MacDonald CFA, Pres, CEO & DirectorMr. Glenn Garry MacNeil CFA, CPA, Chief Financial Officer (Age 60)Mr. Robert Terrance Kittel CFA, CPA, Chief Operating Officer (Age 47)Mr. Joseph Arthur Schenk, Managing Director (Age 60) How do I buy shares of Westaim? Shares of WEDXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Westaim's stock price today? One share of WEDXF stock can currently be purchased for approximately $1.87. How big of a company is Westaim? Westaim has a market capitalization of $267.77 million and generates $3.70 million in revenue each year. Westaim employs 8 workers across the globe. What is Westaim's official website? The official website for Westaim is http://www.westaim.com. How can I contact Westaim? Westaim's mailing address is 70 York Street Suite 1700, Toronto A6, M5J 1S9. The company can be reached via phone at 416-969-3333 or via email at [email protected] MarketBeat Community Rating for Westaim (OTCMKTS WEDXF)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 37 (Vote Outperform)Underperform Votes: 31 (Vote Underperform)Total Votes: 68MarketBeat's community ratings are surveys of what our community members think about Westaim and other stocks. Vote "Outperform" if you believe WEDXF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WEDXF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: Why Invest in Dividend Achievers?